- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 225/02 - Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom not condensed with other rings
Patent holdings for IPC class C07D 225/02
Total number of patents in this class: 146
10-year publication summary
|
17
|
9
|
9
|
10
|
7
|
9
|
13
|
5
|
7
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Ube Industries, Ltd. | 849 |
11 |
| Nocion Therapeutics, Inc. | 42 |
9 |
| Evonik Operations GmbH | 4105 |
8 |
| The Regents of the University of California | 19918 |
6 |
| Hanwha Solutions Corporation | 826 |
6 |
| Massachusetts Institute of Technology | 10057 |
5 |
| SynAffix B.V. | 107 |
5 |
| Bristol-myers Squibb Company | 4898 |
3 |
| Life Technologies Corporation | 3298 |
3 |
| Toray Industries, Inc. | 6936 |
3 |
| Advansix Resins & Chemicals LLC | 299 |
3 |
| BioTheryX, Inc. | 100 |
3 |
| Daicel Chemical Industries, Ltd. | 227 |
3 |
| The Trustees of Boston College | 200 |
3 |
| University of Southampton | 443 |
3 |
| West China Hospital, Sichuan University | 198 |
3 |
| Ube Corporation | 354 |
3 |
| BASF SE | 20933 |
2 |
| European Molecular Biology Laboratory | 313 |
2 |
| Givaudan SA | 1866 |
2 |
| Other owners | 60 |